(16015810), N. J., (16015813), K. R. C., (14958336), H. H. M., (14942629), S. R., (16015816), C. T., (15038249), C. A. W., . . . (14942641), R. O. H. (2025). Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Chicago Style (17th ed.) Citation(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.
MLA (9th ed.) Citation(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.